HER2-Positive Breast Cancer: Current Approaches for Quality Care
Listen in as expert faculty discuss their approaches to and key studies for current management of patients with HER2-positive breast cancer, as well as potential implications of new data in clinical practice.
Decera Clinical Education Oncology Podcast · Erika P Hamilton MD, Komal Jhaveri MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Erika P. Hamilton, MD, and Komal Jhaveri, MD, discuss their approaches to and key studies for current management of patients with HER2-positive breast cancer. The discussion includes:
- Optimizing systemic therapy for patients with HER2-positive early breast cancer based on disease characteristics and risk
- Sequencing available therapies for patients with HER2-positive metastatic disease, including new data on first- and second-line therapy and how to manage patients with central nervous system metastases
- Managing common adverse events associated with HER2-targeted therapy
Presenters:
Erika P. Hamilton, MD
Director, Breast and Gynecologic Cancer Research Program
Drug Development Unit
Sarah Cannon Research Institute
Investigator
Tennessee Oncology
Nashville, Tennessee
Komal Jhaveri, MD
Assistant Professor of Medicine
Weill Cornell Medical College
Associate Attending Physician
Breast Medicine Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Follow along with Podcast Pearls slideset:
https://bit.ly/3eMqxB8
See full program:
https://bit.ly/3oBdd45
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.